Biotech: Page 30

  • A collage of pnk, blue and orange bacteria-like blobs float around against a dark blue background.
    Image attribution tooltip
    Getty Images
    Image attribution tooltip

    Taking probiotics where they’ve never gone before

    How Seed Health is transforming the microbiome therapeutic market with its pharma-focused drug development approach.

    By Karissa Waddick • Aug. 2, 2022
  • Catherine Owen
    Image attribution tooltip

    Permission granted by Catherine Owen.

    Image attribution tooltip
    Q&A

    A glimpse inside Bristol Myers Squibb’s integration with Celgene

    Catherine Owen, senior vice president of major markets, discusses the hurdles — and successes — of bringing the two ‘powerhouses’ together.

    By • Aug. 1, 2022
  • cancer R&D Explore the Trendline➔
    Image attribution tooltip
    Getty Images
    Image attribution tooltip
    Trendline

    Oncology R&D

    Cancer research remains a prime focus for the industry and often leads to pharma’s most impactful breakthroughs.   

    By PharmaVoice staff
  • Artifical intelligence
    Image attribution tooltip
    Getty Images
    Image attribution tooltip
    Q&A

    How a speech analysis tool could transform diagnosis and research for Alzheimer’s and beyond

    WinterLight’s machine learning platform assesses speech to more accurately identify neurodegenerative diseases.

    By Kim Ribbink • Aug. 1, 2022
  • A person points a pen at a computer with a green line graph. A blurred computer in the background shows other graphs.
    Image attribution tooltip
    Getty Images
    Image attribution tooltip

    What’s next for Biogen? Here’s what executives are saying

    A trickling launch for Aduhelm and a middling earnings report give Biogen executives a lot to talk about. Is there hope?

    By • July 27, 2022
  • A view of the Capitol Dome from below with an American flag waving in the wind on the left side and blue skies in the background.
    Image attribution tooltip
    Getty Images
    Image attribution tooltip

    Democrats think they've found a balance between drug innovation and pricing negotiation

    A look at Congress’ push to pass drug pricing reform and why the latest attempt could actually succeed.

    By Karissa Waddick • July 26, 2022
  • A man walks out of the Pfizer world headquarters building.
    Image attribution tooltip
    Chris Hondros / Staff via Getty Images
    Image attribution tooltip
    Q&A

    Behind Pfizer's new quest to target a 'transformation' in pharma

    A combined venture with Roivant — called Priovant Therapeutics — is looking to be a forerunner in the burgeoning autoimmune disease market.

    By Kelly Bilodeau • July 25, 2022
  • Neuron
    Image attribution tooltip
    Getty Images
    Image attribution tooltip

    A 'total waste'? Drug developers worry if two decades of Alzheimer's research were pointed at the wrong targets

    The latest trial failures in Alzheimer's have shown cracks in the foundation of ingrained theories like amyloid plaque clearance. What will it take to move forward?

    By • July 25, 2022
  • newborn screening
    Image attribution tooltip
    Getty Images
    Image attribution tooltip

    The earlier the better: New consortium leverages infant screening to accelerate treatment

    Inozyme Pharma has joined a genomic sequencing program developing a novel rapid test for 388 genetic diseases.

    By Kim Ribbink • July 25, 2022
  • A red Moderna sign hangs on the front of a beige building.
    Image attribution tooltip
    Maddie Meyer / Staff via Getty Images
    Image attribution tooltip

    Moderna's next vax target? A little-known cause of birth defects

    How the mRNA-based biotech is developing the first-ever prophylactic for a devastating virus.

    By Karissa Waddick • July 21, 2022
  • MeiMei Hu Headshot
    Image attribution tooltip
    Diego Camargo/PharmaVoice
    Image attribution tooltip
    Podcast

    Woman of the Week: Vaxxinity's Mei Mei Hu

    Mei Mei Hu is looking to lead a third biologic ‘revolution’ by developing vaccines for chronic diseases.

    By • July 20, 2022
  • A person wearing a purple latex glove holds a petri dish with pink and red spots vertically with their thumb and index finger.
    Image attribution tooltip
    Getty Images
    Image attribution tooltip

    By the numbers: The rising danger of superbugs

    A look at how the COVID-19 pandemic exacerbated one of the world’s greatest public health concerns.

    By Karissa Waddick • July 20, 2022
  • R&D costs
    Image attribution tooltip
    Getty Images
    Image attribution tooltip

    Biotech R&D spending has skyrocketed, and so have opportunities for savings

    With R&D costs on the rise, biotechs are embracing new strategies and technologies to make spending more efficient.

    By • July 19, 2022
  • A person holds a magnet pointed at multi-colored wooden figures of people sitting on dark wood-grain table.
    Image attribution tooltip
    Getty Images
    Image attribution tooltip
    Making Moves

    Making moves: Agios, BeiGene, Biocom California and more announce new key hires

    The latest executive personnel changes from around the industry.

    By Karissa Waddick • July 18, 2022
  • gene therapy
    Image attribution tooltip
    Getty Images
    Image attribution tooltip
    Q&A // First 90 Days

    Anjarium Biosciences’ CEO on its next-gen gene therapies

    Stephen Yoo aims to build on the buzz around the company’s leading-edge gene therapy tech.

    By Kim Ribbink • July 15, 2022
  • A grey exterior sign with Alkermes' written on it sits in a bed of flowers outside a glass office building.
    Image attribution tooltip
    Permission granted by Karissa Waddick
    Image attribution tooltip

    Alkermes looks to fill cancer treatment gaps with new immune pathways

    The company’s chief medical officer discusses its lead candidate and how it fits into wider oncology trends.

    By Kelly Bilodeau • July 14, 2022
  • Image attribution tooltip
    Diego Camargo/PharmaVoice
    Image attribution tooltip
    Podcast

    Woman of the Week: Kura Oncology's Kirsten Flowers

    How the chief commercial and corporate strategy officer is embracing a ‘full-cup’ philosophy to build a better leadership toolbox.

    By • July 13, 2022
  • Business person working at laptop computer and digital documents with checkbox lists.
    Image attribution tooltip
    Getty Images
    Image attribution tooltip

    Why a 'fundamental shift' in regulatory submissions is on the way

    Deloitte's senior manager of R&D and regulatory practices explains how technology and strategy must converge to smooth out the bulky drug approval process.

    By • July 11, 2022
  • Image attribution tooltip
    Getty Images
    Image attribution tooltip

    Precision closes in on what could become the first 'off-the-shelf' CAR-T cell therapy

    Precision BioSciences’ CEO discusses the company’s potentially groundbreaking cancer treatment.

    By Kelly Bilodeau • July 7, 2022
  • Image attribution tooltip
    Getty Images
    Image attribution tooltip
    Q&A

    The CEO of Dr. Reddy's N. America is using 'controlled explosions' to keep the generics giant growing

    Marc Kikuchi weighs in on the company’s plans to pump up its pipeline and sales in the coming years.

    By • July 7, 2022
  • Image attribution tooltip
    Getty Images
    Image attribution tooltip

    How Big Pharma is prepping for the late 2020s patent cliff

    Ratings agency Moody’s lays out the risk exposure for industry leaders.

    By Kim Ribbink • July 6, 2022
  • Image attribution tooltip
    Diego Camargo/PharmaVoice
    Image attribution tooltip
    Podcast

    Woman of the Week: CinCor Pharma's Terry Coelho

    From M&Ms to biotech, the chief financial officer's sweet tooth for taking risks is paying off. 

    By • July 6, 2022
  • Geometric illustration of multi-colored human figures
    Image attribution tooltip
    Getty Images
    Image attribution tooltip

    Pharma companies take a fresh approach to inclusion in new DTC ads

    AstraZeneca and Amgen are emphasizing diversity and authenticity in campaigns for lupus and severe asthma therapies.

    By Karissa Waddick • July 5, 2022
  • Image attribution tooltip
    Getty Images
    Image attribution tooltip
    Q&A // Biotech Spotlight

    Biotech spotlight: Twist Bioscience aims to remove limits on drug discovery with DNA synthesis platform

    As ‘the Amazon of DNA,’ Twist CSO, Aaron Sato, discusses the company’s breakthrough approach to DNA production and its expansion into drug development.

    By Kim Ribbink • June 30, 2022
  • A magnifying glass is held over a wooden block with a business person's silhouette etched on it.
    Image attribution tooltip
    Getty Images
    Image attribution tooltip
    Making Moves

    Making moves: Walgreens, Merck, eClinical Solutions and more announce key new hires

    The latest personnel changes from around the industry.

    By Karissa Waddick • June 29, 2022
  • Katalin Kariko and Drew Weissman
    Image attribution tooltip
    Permission granted by University of Pennsylvania
    Image attribution tooltip
    Q&A

    The scientist's struggle: Lessons from the journey of mRNA pioneers Katalin Karikó and Drew Weissman

    The two Penn Medicine researchers whose work brought the mRNA vaccines into COVID-19 fruition want to see the pharma world embrace early science.

    By • June 29, 2022